Alert: New Earnings Report (11/8/23)-Ligand Pharmaceuticals Inc (NASDAQ: LGND).
For its third fiscal quarter (ending September 30), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported a -154% decline in E.P.S. from $1.37 a year ago to $-0.74 in the current quarter. This performance was $-1.36 […]